NEW YORK (GenomeWeb News) – BG Medicine has tapped Paul Sohmer to be president, CEO, and a member of its board of directors, effective immediately, the company said this week.

Sohmer previously was CEO of several medical device and diagnostics companies, including Pathway Diagnostics, Viracor-IBT Laboratories, and Orthocon, and he was chairman, president, and CEO of TriPath Imaging before it was acquired by Becton Dickinson.

Early in his career, Sohmer also was CEO of Genetrix, a genetic testing lab that was acquired by Genzyme.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.